Thierry Bernard's most recent trade in Neogen Corp. was a trade of 17,207 Common Stock (Right to Buy) done . Disclosure was reported to the exchange on Nov. 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neogen Corp. | Thierry Bernard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 17,207 | 17,207 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | Thierry Bernard | Director | Grant, award, or other acquisition of securities at price $ 14.44 per share. | 01 Nov 2024 | 5,620 | 5,620 | - | 14.4 | 81,153 | Restricted Stock Units |
| T2 Biosystems Inc | Thierry Bernard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 1,550 | 4,568 (0%) | 0% | - | Common Stock | |
| T2 Biosystems Inc | Thierry Bernard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 1,550 | 0 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Thierry Bernard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 454 | 0 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Thierry Bernard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2023 | 454 | 5,022 (0%) | 0% | - | Common Stock | |
| T2 Biosystems Inc | Thierry Bernard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2022 | 115,000 | 115,000 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Thierry Bernard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2022 | 22,727 | 22,727 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Thierry Bernard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2022 | 22,727 | 150,936 (0%) | 0% | - | Common Stock | |
| T2 Biosystems Inc | Thierry Bernard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2022 | 73,224 | 128,209 (0%) | 0% | - | Common Stock | |
| T2 Biosystems Inc | Thierry Bernard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2022 | 73,224 | 0 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Thierry Bernard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 77,519 | 77,519 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Thierry Bernard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2022 | 32,258 | 54,985 (0%) | 0% | - | Common Stock | |
| T2 Biosystems Inc | Thierry Bernard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2022 | 32,258 | 0 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Thierry Bernard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2021 | 22,727 | 22,727 (0%) | 0% | - | Common Stock | |
| T2 Biosystems Inc | Thierry Bernard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2021 | 22,727 | 45,454 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Thierry Bernard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 73,224 | 73,224 | - | - | Restricted Stock Units | |
| T2 Biosystems Inc | Thierry Bernard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 32,258 | 32,258 | - | - | Restricted Stock Units |